S. Sharma et al., TRANSTHORACIC ECHOCARDIOGRAPHIC FINDINGS IN PATIENTS WITH ACUTE RETINAL ARTERIAL-OBSTRUCTION - A RETROSPECTIVE REVIEW, Archives of ophthalmology, 114(10), 1996, pp. 1189-1192
Objective: To assess the importance of cardio-embolic (emboli of cardi
ac origin) risk stratification in the cardiac evaluation of patients w
ith acute retinal arterial obstruction. Design: A multicenter retrospe
ctive study of patients with acute retinal arterial obstruction who un
derwent transthoracic echocardiography. Settings: Four North American
hospital centers. Patients: One hundred patients with acute retinal ar
tery obstruction in whom transthoracic echocardiography was performed.
Main Outcome Measure: Anticoagulation or cardiac surgery based on abn
ormalities detected on transthoracic echocardiography. Transesophageal
echocardiographic results were not evaluated, as they were rarely per
formed in our centers. Thus, the outcome measure was determined solely
by the results of transthoracic echocardiography. Results: Patients w
ere divided into high- and low-risk groups based on their history of c
ardioembolic risk factors or the presence of a cardiac murmur. Of 67 p
atients with no risk factors, 41 (61%) had normal echocardiographic st
udy results and 26 (39%) had abnormalities detected, of whom only 1 (1
.5%) received anticoagulation or cardiac surgery. The presence of 1 or
more cardioembolic risk factors increased the likelihood for anticoag
ulation or cardiac surgery 25 times (odds ratio=25; 95% confidence int
erval=3.04-217.02). Although this result is clinically and statistical
ly significant, it is possible that abnormalities missed by transthora
cic methods may have been detected by transesophageal technology. Conc
lusions: In patients with acute retinal arterial obstruction at low ca
rdioembolic risk, transthoracic echocardiography resulted in anticoagu
lation or cardiac surgery in 1 (1.5%) of 67 patients. Routine transtho
racic echocardiography without follow-up transesophageal echocardiogra
phy for patients identified as having abnormalities such as left ventr
icular hypertrophy or mitral annular calcification and who are at low
cardioembolic risk rarely resulted in anticoagulation or cardiac surge
ry.